Form D · Other Health Care

CROSSCURRENT INC

Portland, OR · CIK 0001433509

Offering snapshot reported Feb 15, 2013 · SEC filing

Reported sold
$650K
Offering amount: $900K
Investors reported
12
Form D · investor count
Minimum accepted
$10K
Reported outside-investor minimum
First sale
Feb 1, 2013
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 15, 2013Initial$650,000No comparison12SEC filing
Jun 17, 2011Initial$1,725,000No comparison14SEC filing
Apr 22, 2008PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
05, 06, 46, 04.3
Duration over one year
No
Business combination
No
Sales commissions
$65K
Finders' fees
$0
Form D file number
021-191979

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Veber Partners LLC39224

Source: Form D, filed Feb 15, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Rodger Adams Director
Chris Baker Director, Executive
John Crudele Director
Harry Demorest Director
Barbara Gaffney Director
Robert Goodman Director
Richard Goodman Director
Dennis Mc Nannay Director
Richard Rothman Director
James Rowe Executive
Paul Schwaegler Director
David Smith Director, Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
5531 Sw Macadam Avenue Suite 216
Portland, OR, 97239